Skip to main content
. 2014 Jan 23;18(4):685–697. doi: 10.1111/jcmm.12217

Figure 3.

Figure 3

Enhanced fibroblast and myofibroblast cells in response to CD34+ cell therapy. Immunofluorescence-mediated detection of (A) fibroblast (SM22-α), and (B) myofibroblast (alpha-smooth muscle actin) cells in the wound bed of animals received CD34+ cells or without cells as a control at various time-points of therapy.